Suppr超能文献

分化型甲状腺癌放射性碘治疗中的个体化剂量测定

Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.

作者信息

Pacilio Massimiliano, Conte Miriam, Frantellizzi Viviana, De Feo Maria Silvia, Pisani Antonio Rosario, Marongiu Andrea, Nuvoli Susanna, Rubini Giuseppe, Spanu Angela, De Vincentis Giuseppe

机构信息

Medical Physics Department, "Policlinico Umberto I" University Hospital, 00161 Rome, Italy.

Department of Radiological Sciences, Oncology and Anatomo-Pathology, Sapienza University of Rome, 00161 Rome, Italy.

出版信息

Diagnostics (Basel). 2022 Jul 21;12(7):1763. doi: 10.3390/diagnostics12071763.

Abstract

The most frequent thyroid cancer is Differentiated Thyroid Cancer (DTC) representing more than 95% of cases. A suitable choice for the treatment of DTC is the systemic administration of 131-sodium or potassium iodide. It is an effective tool used for the irradiation of thyroid remnants, microscopic DTC, other nonresectable or incompletely resectable DTC, or all the cited purposes. Dosimetry represents a valid tool that permits a tailored therapy to be obtained, sparing healthy tissue and so minimizing potential damages to at-risk organs. Absorbed dose represents a reliable indicator of biological response due to its correlation to tissue irradiation effects. The present paper aims to focus attention on iodine therapy for DTC treatment and has developed due to the urgent need for standardization in procedures, since no unique approaches are available. This review aims to summarize new proposals for a dosimetry-based therapy and so explore new alternatives that could provide the possibility to achieve more tailored therapies, minimizing the possible side effects of radioiodine therapy for Differentiated Thyroid Cancer.

摘要

最常见的甲状腺癌是分化型甲状腺癌(DTC),占病例的95%以上。治疗DTC的一个合适选择是全身给予131碘化钠或碘化钾。它是用于照射甲状腺残余组织、微小DTC、其他不可切除或不完全可切除的DTC或所有上述目的的有效工具。剂量测定是一种有效的工具,可实现量身定制的治疗,保护健康组织,从而将对高危器官的潜在损害降至最低。吸收剂量由于其与组织照射效应的相关性,是生物反应的可靠指标。本文旨在关注用于DTC治疗的碘治疗,由于迫切需要规范程序,因为目前尚无统一的方法,因此撰写了本文。本综述旨在总结基于剂量测定的治疗的新建议,从而探索新的替代方法,这些方法可能提供实现更个性化治疗的可能性,将分化型甲状腺癌放射性碘治疗的可能副作用降至最低。

相似文献

1
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.
Diagnostics (Basel). 2022 Jul 21;12(7):1763. doi: 10.3390/diagnostics12071763.
3
Dosimetry in differentiated thyroid carcinoma (12-1402R).
Med Phys. 2013 Jan;40(1):012502. doi: 10.1118/1.4769426.
8
Initial results of the INSPIRE clinical trial-investigating radiation dosimetry for differentiated thyroid cancer patients.
Front Nucl Med. 2023 May 15;3:964478. doi: 10.3389/fnume.2023.964478. eCollection 2023.
9
Radioiodine ablation: when and how.
Q J Nucl Med Mol Imaging. 2009 Oct;53(5):473-81.

引用本文的文献

3
Advances in targeted therapy and biomarker research in thyroid cancer.
Front Endocrinol (Lausanne). 2024 Mar 4;15:1372553. doi: 10.3389/fendo.2024.1372553. eCollection 2024.
4
An Artificial Intelligence System for Optimizing Radioactive Iodine Therapy Dosimetry.
J Clin Med. 2023 Dec 25;13(1):117. doi: 10.3390/jcm13010117.
6
Radioactive Iodine in Differentiated Carcinoma of Thyroid: An Overview.
Curr Radiopharm. 2024;17(1):2-6. doi: 10.2174/0118744710249684231013072013.
7
Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment.
Cancers (Basel). 2023 Jan 25;15(3):740. doi: 10.3390/cancers15030740.
9
Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer.
Cancer Imaging. 2022 Dec 9;22(1):67. doi: 10.1186/s40644-022-00505-y.

本文引用的文献

2
Risk Factors for Thyroid Cancer: What Do We Know So Far?
Acta Clin Croat. 2020 Jun;59(Suppl 1):66-72. doi: 10.20471/acc.2020.59.s1.08.
5
Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update.
AJR Am J Roentgenol. 2020 Aug;215(2):285-291. doi: 10.2214/AJR.19.22626. Epub 2020 Jun 17.
6
Personalised Dosimetry in Radioembolisation for HCC: Impact on Clinical Outcome and on Trial Design.
Cancers (Basel). 2020 Jun 12;12(6):1557. doi: 10.3390/cancers12061557.
7
Radioembolization of hepatocarcinoma with Y glass microspheres: treatment optimization using the dose-toxicity relationship.
Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3018-3032. doi: 10.1007/s00259-020-04845-4. Epub 2020 May 25.
8
Targeted Alpha Therapy with Thorium-227.
Cancer Biother Radiopharm. 2020 Aug;35(6):437-445. doi: 10.1089/cbr.2019.3105. Epub 2020 Jan 20.
10
Major limits of dosimetrically determined activities in advanced differentiated thyroid carcinoma.
Q J Nucl Med Mol Imaging. 2019 Sep;63(3):258-266. doi: 10.23736/S1824-4785.19.03211-4. Epub 2019 Sep 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验